NEW YORK, Sept. 17 (GenomeWeb News) - Stratagene said yesterday that a patent infringement lawsuit Third Wave filed against it on Wednesday is without  merit.

"We are surprised that Third Wave would file this lawsuit before discussing with us the differences in the two companies' technologies," Joseph Sorge, Stratagene's chairman and CEO, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.